Hypertension is associated with the reduction in epidermal small fibres independently of sural nerve inflammation in type 2 diabetic subjects
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated w...
Saved in:
Published in | Journal of neurochemistry Vol. 169; no. 2; pp. e16235 - n/a |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.02.2025
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.
In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation. |
---|---|
AbstractList | Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206
/CD68
proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206
/CD68
anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206
and CD206
macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206
macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM ( p < 0.05) and was further decreased in DMHT ( p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM ( p < 0.05) and further decreased in DMHT ( p < 0.01 vs. DM). The infiltration of CD206 − /CD68 + proinflammatory macrophages in the SN was significantly increased in DM compared to nDM ( p < 0.05), whilst the number of CD206 + /CD68 + anti‐inflammatory macrophages was decreased in DM ( p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206 − and CD206 + macrophage was negatively correlated with MNFD ( r = 0.42, p < 0.05) but not IENFD ( r = 0.30, p = 0.09). Dermal CD206 + macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness ( p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD ( r = ‐0.59, p < 0.01) and MNFD ( r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. image Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation. Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206-/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206- and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206-/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206- and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM ( p < 0.05) and was further decreased in DMHT ( p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM ( p < 0.05) and further decreased in DMHT ( p < 0.01 vs. DM). The infiltration of CD206 − /CD68 + proinflammatory macrophages in the SN was significantly increased in DM compared to nDM ( p < 0.05), whilst the number of CD206 + /CD68 + anti‐inflammatory macrophages was decreased in DM ( p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206 − and CD206 + macrophage was negatively correlated with MNFD ( r = 0.42, p < 0.05) but not IENFD ( r = 0.30, p = 0.09). Dermal CD206 + macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness ( p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD ( r = ‐0.59, p < 0.01) and MNFD ( r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation. |
Author | Wang, Zhenchao Osonoi, Sho Miura, Chinatsu Yagihashi, Soroku Ryuzaki, Masaki Kushibiki, Hanae Sasaki, Takanori Tarusawa, Takefusa Ogasawara, Saori Mizukami, Hiroki |
AuthorAffiliation | 1 Department of Pathology and Molecular Medicine, Biomedical Research Center Hirosaki University Graduate School of Medicine Hirosaki Japan |
AuthorAffiliation_xml | – name: 1 Department of Pathology and Molecular Medicine, Biomedical Research Center Hirosaki University Graduate School of Medicine Hirosaki Japan |
Author_xml | – sequence: 1 givenname: Zhenchao surname: Wang fullname: Wang, Zhenchao organization: Hirosaki University Graduate School of Medicine – sequence: 2 givenname: Hanae surname: Kushibiki fullname: Kushibiki, Hanae organization: Hirosaki University Graduate School of Medicine – sequence: 3 givenname: Takefusa surname: Tarusawa fullname: Tarusawa, Takefusa organization: Hirosaki University Graduate School of Medicine – sequence: 4 givenname: Sho surname: Osonoi fullname: Osonoi, Sho organization: Hirosaki University Graduate School of Medicine – sequence: 5 givenname: Saori surname: Ogasawara fullname: Ogasawara, Saori organization: Hirosaki University Graduate School of Medicine – sequence: 6 givenname: Chinatsu surname: Miura fullname: Miura, Chinatsu organization: Hirosaki University Graduate School of Medicine – sequence: 7 givenname: Takanori surname: Sasaki fullname: Sasaki, Takanori organization: Hirosaki University Graduate School of Medicine – sequence: 8 givenname: Masaki surname: Ryuzaki fullname: Ryuzaki, Masaki organization: Hirosaki University Graduate School of Medicine – sequence: 9 givenname: Soroku surname: Yagihashi fullname: Yagihashi, Soroku organization: Hirosaki University Graduate School of Medicine – sequence: 10 givenname: Hiroki orcidid: 0000-0003-2920-582X surname: Mizukami fullname: Mizukami, Hiroki email: hirokim@hirosaki‐u.ac.jp organization: Hirosaki University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39453752$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks9uFSEUxompsbfVhS9gSNzoYlpgYP6sjLmpbU1TN7omDBy83MzACEyb-xB9Z7G3bdSkLA6L78d3PnLOETrwwQNCbyk5oeWcbr0-oQ2rxQu0orylFaeiP0ArQhirasLZITpKaUsIbXhDX6HDuueibgVbobuL3Qwxg08ueOwSVikF7VQGg29d3uC8ARzBLDrfAx7D7AzESY04lTJi64YIqSgGZijF53GHg8VpiYXxEG-giHZU06QePXJpihk2Tg2QnS7ssAWd02v00qoxwZuH-xj9-HL2fX1RXX07v1x_vqo0J1xUPbPGdoL2qhU9H2zLQVgGqjaN6nqmxdBaA51lFlTfWGiZqY2xWtgGLJihPkaf9r7zMkxgdAldwso5uknFnQzKyX8V7zbyZ7iRlHak46IpDh8eHGL4tUDKcnJJwzgqD2FJsqaM9GU2jBT0_X_oNizRl_8VqiUt44KyQr37O9JTlsdRFeDjHtAxpBTBPiGUyD9rIMsayPs1KOzpnr11I-yeB-XX6_X-xW-25bgb |
Cites_doi | 10.2337/dc09‐0554 10.1093/ajh/hpz058 10.1189/jlb.0512231 10.3390/ijms22010094 10.1111/j.1742‐7843.2011.00758.x 10.1016/j.neulet.2004.03.014 10.3390/ijms21218306 10.1293/tox.2020‐0003 10.1002/dmr.5610110304 10.1002/mus.25098 10.1007/s12026‐014‐8548‐6 10.4103/1673‐5374.253510 10.1242/dmm.033647 10.1177/000331977102200904 10.1080/14397595.2020.1830484 10.1016/j.nbd.2013.07.019 10.1111/j.1365‐2362.2010.02430.x 10.1016/S0140‐6736(98)02478‐7 10.1212/wnl.37.1.20 10.1016/j.nbd.2021.105392 10.1016/j.nbd.2022.105839 10.1056/NEJMoa032782 10.4049/jimmunol.1700373 10.1186/1742‐2094‐10‐64 10.1016/j.neuron.2017.02.005 10.1172/jci.insight.160555 10.1136/jcp.38.9.1030 10.1136/bmjdrc‐2020‐001739 10.1016/j.metabol.2020.154232 10.1002/(SICI)1097‐4598(199606)19:6<722::AID‐MUS6>3.0.CO;2‐C 10.1016/j.pain.2012.01.021 10.1007/s00401‐012‐1012‐6 10.1016/B978‐0‐444‐53480‐4.00001‐1 10.2337/diab.40.9.1090 10.1093/brain/awr228 10.1093/braincomms/fcaa168 10.1161/HYPERTENSIONAHA.111.174474 10.1007/s00401‐015‐1482‐4 10.1136/bmj.317.7160.703 10.1097/01.mnh.0000203189.57513.76 10.2337/diab.46.4.665 10.1212/wnl.60.1.108 10.1002/1520‐7560(200009/10)16:5<354::aid‐dmrr149>3.0.co;2‐h 10.1080/1028415X.2024.2383082 10.1007/BF00505180 10.1093/braincomms/fcae103 10.1212/NXI.0000000000001111 10.1111/j.1365‐2249.2005.02934.x 10.1007/s11892‐016‐0727‐5 10.1186/s13098‐015‐0005‐8 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. 2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. 2024. This work is published under Creative Commons Attribution – Non-Commercial – No Derivatives License~http://creativecommons.org/licenses/by-nc-nd/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. – notice: 2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. – notice: 2024. This work is published under Creative Commons Attribution – Non-Commercial – No Derivatives License~http://creativecommons.org/licenses/by-nc-nd/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1111/jnc.16235 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Virology and AIDS Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
DocumentTitleAlternate | Wang et al |
EISSN | 1471-4159 |
EndPage | n/a |
ExternalDocumentID | PMC11808456 39453752 10_1111_jnc_16235 JNC16235 |
Genre | researchArticle Journal Article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PKN PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c4045-92fdf8519a7594bf74e5f2ea3d6a892c5b7fde8f2fea96fe72d3ddfc5f6efedb3 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 1471-4159 |
IngestDate | Thu Aug 21 18:28:19 EDT 2025 Fri Jul 11 03:18:40 EDT 2025 Sat Jul 12 03:05:14 EDT 2025 Mon Jul 21 05:58:09 EDT 2025 Tue Jul 01 04:41:08 EDT 2025 Tue Feb 25 10:00:12 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | macrophages diabetic polyneuropathy IENFD autopsy hypertension |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4045-92fdf8519a7594bf74e5f2ea3d6a892c5b7fde8f2fea96fe72d3ddfc5f6efedb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2920-582X |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16235 |
PMID | 39453752 |
PQID | 3170724512 |
PQPubID | 31528 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11808456 proquest_miscellaneous_3120911120 proquest_journals_3170724512 pubmed_primary_39453752 crossref_primary_10_1111_jnc_16235 wiley_primary_10_1111_jnc_16235_JNC16235 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2025 |
PublicationDateYYYYMMDD | 2025-02-01 |
PublicationDate_xml | – month: 02 year: 2025 text: February 2025 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York – name: Hoboken |
PublicationTitle | Journal of neurochemistry |
PublicationTitleAlternate | J Neurochem |
PublicationYear | 2025 |
Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
References | 2004; 362 2022; 173 2012; 124 1997; 46 2019; 14 1998; 317 2017; 198 2011; 58 2014; 62 1998; 352 1987; 37 2020; 8 2015; 130 2021; 31 2020; 2 2000; 16 1989; 32 2005; 142 2024; 6 2013; 10 1991; 40 2014; 59 2021; 155 2024; 25 2014; 126 2021; 9 1971; 22 1996; 19 2005; 352 2019; 32 1995; 11 2006; 15 2016; 54 2020; 107 2020; 33 2016; 16 2015; 7 2011; 134 2012; 92 2012; 153 2012; 110 2009; 32 2017; 93 2022; 7 2011; 41 2020; 22 2020; 21 2003; 60 2018; 11 1985; 38 e_1_2_13_24_1 e_1_2_13_49_1 e_1_2_13_26_1 e_1_2_13_47_1 e_1_2_13_20_1 e_1_2_13_45_1 e_1_2_13_22_1 e_1_2_13_43_1 e_1_2_13_8_1 e_1_2_13_41_1 e_1_2_13_6_1 e_1_2_13_17_1 e_1_2_13_19_1 e_1_2_13_13_1 e_1_2_13_36_1 e_1_2_13_15_1 e_1_2_13_38_1 e_1_2_13_32_1 e_1_2_13_11_1 e_1_2_13_34_1 e_1_2_13_51_1 e_1_2_13_30_1 e_1_2_13_4_1 e_1_2_13_2_1 e_1_2_13_29_1 e_1_2_13_25_1 e_1_2_13_48_1 e_1_2_13_27_1 e_1_2_13_46_1 e_1_2_13_21_1 e_1_2_13_44_1 e_1_2_13_23_1 e_1_2_13_42_1 e_1_2_13_9_1 e_1_2_13_40_1 e_1_2_13_7_1 e_1_2_13_18_1 e_1_2_13_39_1 e_1_2_13_14_1 e_1_2_13_35_1 e_1_2_13_16_1 e_1_2_13_37_1 e_1_2_13_10_1 e_1_2_13_31_1 e_1_2_13_12_1 e_1_2_13_33_1 e_1_2_13_50_1 e_1_2_13_5_1 e_1_2_13_3_1 e_1_2_13_28_1 |
References_xml | – volume: 38 start-page: 1030 issue: 9 year: 1985 end-page: 1038 article-title: Small vessel disease in progressive diabetic neuropathy associated with good metabolic control publication-title: Journal of Clinical Pathology – volume: 142 start-page: 481 issue: 3 year: 2005 end-page: 489 article-title: Macrophage activation switching: An asset for the resolution of inflammation publication-title: Clinical and Experimental Immunology – volume: 32 start-page: 92 issue: 2 year: 1989 end-page: 102 article-title: Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy publication-title: Diabetologia – volume: 16 start-page: 29 issue: 3 year: 2016 article-title: Inflammation as a therapeutic target for diabetic neuropathies publication-title: Current Diabetes Reports – volume: 93 start-page: 1296 issue: 6 year: 2017 end-page: 1313 article-title: New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain publication-title: Neuron – volume: 153 start-page: 982 issue: 5 year: 2012 end-page: 989 article-title: Epidermal Langerhans cells in small fiber neuropathies publication-title: Pain – volume: 352 start-page: 1978 issue: 9145 year: 1998 end-page: 1981 article-title: Effect of angiotensin‐converting‐enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised double‐blind controlled trial publication-title: Lancet – volume: 126 start-page: 3 year: 2014 end-page: 22 article-title: Epidemiology of polyneuropathy in diabetes and prediabetes publication-title: Handbook of Clinical Neurology – volume: 22 issue: 1 year: 2020 article-title: Pathogenesis and molecular treatment strategies of diabetic neuropathy collateral glucose‐utilizing pathways in diabetic polyneuropathy publication-title: International Journal of Molecular Sciences – volume: 32 start-page: 1896 issue: 10 year: 2009 end-page: 1900 article-title: Large‐fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors publication-title: Diabetes Care – volume: 92 start-page: 1177 issue: 6 year: 2012 end-page: 1186 article-title: The mannose receptor publication-title: Journal of Leukocyte Biology – volume: 32 start-page: 796 issue: 8 year: 2019 end-page: 803 article-title: Hypertension contributes to neuropathy in patients with type 1 diabetes publication-title: American Journal of Hypertension – volume: 173 year: 2022 article-title: The diversity and abundance of gut microbiota are associated with the pain sensation threshold in the Japanese population publication-title: Neurobiology of Disease – volume: 198 start-page: 3775 issue: 10 year: 2017 end-page: 3789 article-title: A consensus definitive classification of scavenger receptors and their roles in health and disease publication-title: Journal of Immunology – volume: 15 start-page: 152 issue: 2 year: 2006 end-page: 158 article-title: Inflammation in hypertension publication-title: Current Opinion in Nephrology and Hypertension – volume: 46 start-page: 665 issue: 4 year: 1997 end-page: 670 article-title: Hypertension as a risk factor for diabetic neuropathy: A prospective study publication-title: Diabetes – volume: 134 start-page: 3222 issue: Pt 11 year: 2011 end-page: 3235 article-title: The identification of gene expression profiles associated with progression of human diabetic neuropathy publication-title: Brain – volume: 60 start-page: 108 issue: 1 year: 2003 end-page: 111 article-title: The spectrum of neuropathy in diabetes and impaired glucose tolerance publication-title: Neurology – volume: 124 start-page: 561 issue: 4 year: 2012 end-page: 573 article-title: Hypertension‐induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats publication-title: Acta Neuropathologica – volume: 37 start-page: 20 issue: 1 year: 1987 end-page: 28 article-title: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy publication-title: Neurology – volume: 6 issue: 2 year: 2024 article-title: Tryptophan metabolism and small fibre neuropathy: A correlation study publication-title: Brain Communication – volume: 7 start-page: 9 year: 2015 article-title: Association of chronic diabetes and hypertension in sural nerve morphometry: An experimental study publication-title: Diabetology and Metabolic Syndrome – volume: 130 start-page: 605 issue: 5 year: 2015 end-page: 618 article-title: Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury publication-title: Acta Neuropathologica – volume: 21 issue: 21 year: 2020 article-title: Increased oxidative stress underlies abnormal pain threshold in a Normoglycemic Japanese population publication-title: International Journal of Molecular Sciences – volume: 22 start-page: 521 year: 1971 end-page: 522 article-title: Hypertension and subclinical peripheral neuropathy publication-title: Angiology – volume: 11 issue: 4 year: 2018 article-title: CD40‐mediated HIF‐1α expression underlying microangiopathy in diabetic nerve pathology publication-title: Disease Models & Mechanisms – volume: 10 year: 2013 article-title: Neurogenic factor‐induced Langerhans cell activation in diabetic mice with mechanical allodynia publication-title: Journal of Neuroinflammation – volume: 107 year: 2020 article-title: Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and β‐cell volume density in spontaneously type 2 diabetic Goto‐Kakizaki rats publication-title: Metabolism – volume: 33 start-page: 161 issue: 3 year: 2020 end-page: 169 article-title: Superimposition of hypertension on diabetic peripheral neuropathy affects small unmyelinated sensory nerves in the skin and myelinated tibial and sural nerves in rats with alloxan‐induced type 1 diabetes publication-title: Journal of Toxicologic Pathology – volume: 11 start-page: 193 issue: 3 year: 1995 end-page: 225 article-title: Pathology and pathogenetic mechanisms of diabetic neuropathy publication-title: Diabetes/Metabolism Reviews – volume: 16 start-page: 354 issue: 5 year: 2000 end-page: 363 article-title: Insulin receptor in rat peripheral nerve: Its localization and alternatively spliced isoforms publication-title: Diabetes/Metabolism Research and Reviews – volume: 40 start-page: 1090 issue: 9 year: 1991 end-page: 1099 article-title: Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor publication-title: Diabetes – volume: 362 start-page: 131 year: 2004 end-page: 135 article-title: Morphological and conduction changes in the sciatic nerve of spontaneously hypertensive rats publication-title: Neuroscience Letters – volume: 58 start-page: 776 issue: 5 year: 2011 end-page: 783 article-title: DEMAND study investigators. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial publication-title: Hypertension – volume: 25 start-page: 1 year: 2024 end-page: 11 article-title: Moderate cryptoxanthin intake correlates with maintenance of a proper PINT index in a general Japanese population publication-title: Nutritional Neuroscience – volume: 317 start-page: 703 issue: 7160 year: 1998 end-page: 713 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group publication-title: BMJ – volume: 14 start-page: 1335 issue: 8 year: 2019 end-page: 1342 article-title: Role of macrophages in peripheral nerve injury and repair publication-title: Neural Regeneration Research – volume: 41 start-page: 442 issue: 4 year: 2011 end-page: 450 article-title: Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats publication-title: European Journal of Clinical Investigation – volume: 7 issue: 23 year: 2022 article-title: RAGE activation in macrophages and development of experimental diabetic polyneuropathy publication-title: JCI Insight – volume: 155 year: 2021 article-title: Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice publication-title: Neurobiology of Disease – volume: 54 start-page: 756 issue: 4 year: 2016 end-page: 762 article-title: Neuropathy in the spontaneously hypertensive rat: An electrophysiological and histological study publication-title: Muscle & Nerve – volume: 31 start-page: 849 issue: 4 year: 2021 end-page: 855 article-title: Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren's syndrome publication-title: Modern Rheumatology – volume: 9 issue: 1 year: 2021 article-title: Analysis of macrophages and peptidergic fibers in the skin of patients with painful diabetic polyneuropathy publication-title: Neurology Neuroimmunology and Neuroinflammation – volume: 110 start-page: 49 issue: 1 year: 2012 end-page: 55 article-title: Small artery remodelling in hypertension publication-title: Basic & Clinical Pharmacology & Toxicology – volume: 352 start-page: 341 issue: 4 year: 2005 end-page: 350 article-title: EURODIAB prospective complications study group. Vascular risk factors and diabetic neuropathy publication-title: The New England Journal of Medicine – volume: 59 start-page: 243 issue: 1–3 year: 2014 end-page: 253 article-title: The immune system and hypertension publication-title: Immunologic Research – volume: 19 start-page: 722 issue: 6 year: 1996 end-page: 727 article-title: Diabetic peripheral neuropathy: A clinicopathologic and immunohistochemical analysis of sural nerve biopsies publication-title: Muscle & Nerve – volume: 8 issue: 1 year: 2020 article-title: Lipopolysaccharide‐binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population publication-title: BMJ Open Diabetes Research & Care – volume: 2 issue: 2 year: 2020 article-title: Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway publication-title: Brain Communication – volume: 62 start-page: 18 year: 2014 end-page: 30 article-title: The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes publication-title: Neurobiology of Disease – ident: e_1_2_13_7_1 doi: 10.2337/dc09‐0554 – ident: e_1_2_13_29_1 doi: 10.1093/ajh/hpz058 – ident: e_1_2_13_20_1 doi: 10.1189/jlb.0512231 – ident: e_1_2_13_22_1 doi: 10.3390/ijms22010094 – ident: e_1_2_13_24_1 doi: 10.1111/j.1742‐7843.2011.00758.x – ident: e_1_2_13_45_1 doi: 10.1016/j.neulet.2004.03.014 – ident: e_1_2_13_26_1 doi: 10.3390/ijms21218306 – ident: e_1_2_13_28_1 doi: 10.1293/tox.2020‐0003 – ident: e_1_2_13_47_1 doi: 10.1002/dmr.5610110304 – ident: e_1_2_13_25_1 doi: 10.1002/mus.25098 – ident: e_1_2_13_38_1 doi: 10.1007/s12026‐014‐8548‐6 – ident: e_1_2_13_17_1 doi: 10.4103/1673‐5374.253510 – ident: e_1_2_13_14_1 doi: 10.1242/dmm.033647 – ident: e_1_2_13_3_1 doi: 10.1177/000331977102200904 – ident: e_1_2_13_49_1 doi: 10.1080/14397595.2020.1830484 – ident: e_1_2_13_6_1 doi: 10.1016/j.nbd.2013.07.019 – ident: e_1_2_13_21_1 doi: 10.1111/j.1365‐2362.2010.02430.x – ident: e_1_2_13_19_1 doi: 10.1016/S0140‐6736(98)02478‐7 – ident: e_1_2_13_48_1 doi: 10.1212/wnl.37.1.20 – ident: e_1_2_13_41_1 doi: 10.1016/j.nbd.2021.105392 – ident: e_1_2_13_42_1 doi: 10.1016/j.nbd.2022.105839 – ident: e_1_2_13_43_1 doi: 10.1056/NEJMoa032782 – ident: e_1_2_13_32_1 doi: 10.4049/jimmunol.1700373 – ident: e_1_2_13_5_1 doi: 10.1186/1742‐2094‐10‐64 – ident: e_1_2_13_8_1 doi: 10.1016/j.neuron.2017.02.005 – ident: e_1_2_13_27_1 doi: 10.1172/jci.insight.160555 – ident: e_1_2_13_44_1 doi: 10.1136/jcp.38.9.1030 – ident: e_1_2_13_15_1 doi: 10.1136/bmjdrc‐2020‐001739 – ident: e_1_2_13_11_1 doi: 10.1016/j.metabol.2020.154232 – ident: e_1_2_13_50_1 doi: 10.1002/(SICI)1097‐4598(199606)19:6<722::AID‐MUS6>3.0.CO;2‐C – ident: e_1_2_13_2_1 doi: 10.1016/j.pain.2012.01.021 – ident: e_1_2_13_10_1 doi: 10.1007/s00401‐012‐1012‐6 – ident: e_1_2_13_51_1 doi: 10.1016/B978‐0‐444‐53480‐4.00001‐1 – ident: e_1_2_13_37_1 doi: 10.2337/diab.40.9.1090 – ident: e_1_2_13_13_1 doi: 10.1093/brain/awr228 – ident: e_1_2_13_23_1 doi: 10.1093/braincomms/fcaa168 – ident: e_1_2_13_33_1 doi: 10.1161/HYPERTENSIONAHA.111.174474 – ident: e_1_2_13_4_1 doi: 10.1007/s00401‐015‐1482‐4 – ident: e_1_2_13_46_1 doi: 10.1136/bmj.317.7160.703 – ident: e_1_2_13_36_1 doi: 10.1097/01.mnh.0000203189.57513.76 – ident: e_1_2_13_9_1 doi: 10.2337/diab.46.4.665 – ident: e_1_2_13_40_1 doi: 10.1212/wnl.60.1.108 – ident: e_1_2_13_39_1 doi: 10.1002/1520‐7560(200009/10)16:5<354::aid‐dmrr149>3.0.co;2‐h – ident: e_1_2_13_34_1 doi: 10.1080/1028415X.2024.2383082 – ident: e_1_2_13_18_1 doi: 10.1007/BF00505180 – ident: e_1_2_13_16_1 doi: 10.1093/braincomms/fcae103 – ident: e_1_2_13_12_1 doi: 10.1212/NXI.0000000000001111 – ident: e_1_2_13_31_1 doi: 10.1111/j.1365‐2249.2005.02934.x – ident: e_1_2_13_30_1 doi: 10.1007/s11892‐016‐0727‐5 – ident: e_1_2_13_35_1 doi: 10.1186/s13098‐015‐0005‐8 |
SSID | ssj0016461 |
Score | 2.46643 |
Snippet | Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension.... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e16235 |
SubjectTerms | Adult Aged Autopsies autopsy Density Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - pathology Diabetic Neuropathies - pathology diabetic polyneuropathy Diffusion barriers Epidermis - innervation Epidermis - pathology Female Humans Hyperglycemia Hypertension Hypertension - complications Hypertension - pathology IENFD Immune system Infiltration Inflammation Inflammation - pathology Inflammatory response Macrophages Macrophages - pathology Male Middle Aged Nerve Fibers - pathology Nerves Original Polyneuropathy Sural nerve Sural Nerve - pathology Thickness |
Title | Hypertension is associated with the reduction in epidermal small fibres independently of sural nerve inflammation in type 2 diabetic subjects |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16235 https://www.ncbi.nlm.nih.gov/pubmed/39453752 https://www.proquest.com/docview/3170724512 https://www.proquest.com/docview/3120911120 https://pubmed.ncbi.nlm.nih.gov/PMC11808456 |
Volume | 169 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SXNpLH0kfTtOgllJ6cbBlyw96CkvDEmgopYEcCkaWR3TJVlvW3kPyH_qfOyM_yDYUSi_GoJEtWzOeT-PRNwBvrY6lyeMyNCmqMM0Qw0I1ZZiU2tiosJFB3o386TybX6Rnl-pyBz6Me2F6fogp4MaW4b_XbOC6bm8bOdlPTM6bN5hzrhYDoi8TdRTTZsUTUzhp5sAq5LN4xp7bvugOwLybJ3kbv3oHdPoIvo1D7_NOro43XX1sbv5gdfzPZ3sMDwdgKk56TXoCO-j2YP_E0aL8x7V4J3yqqI_B78H92Vgmbh9-zWklu_Z58CsnFq3Qw4RjIzjIKwhhijUTxHZewAnkorTkD5aipcNSWBoqtmIxFeTtltdiZUXLjCDCcUomNVpS3X6bJV-DI8dCij5yvDAkW3NAqX0KF6cfv87m4VDjgZSD0GRYSttYQn2lzlWZ1jYnlbESddJkuiilUXVuGyystKjLzGIum6RprFE2Q4tNnTyDXbdy-AIEYReaKVNYE5epok5I4K5QaFNTF0qZAN6Ms1397Kk8qmkJ5EzlX3gAh6MeVIM1txVhrCiXKWGjAF5PzfSe-eeKdrjasIyM2HHIKIDnvdpMd0loPEmuqHexpVCTAHN8b7e4xXfP9c0MfQWB3ADee4X5-8irs_OZPzn4d9GX8EByPWOfhX4Iu916g68IZHX1EdyT6ecjb1O_AbYXKiQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VciiXAi3QQAGDEOKSKnHiPCQu1YpqKe0eUCv1gqLE8YgVixdtsofyH_jPzDgPdamQEJcokseJE89kPk_G3wC8wTKUOg1zX8dG-XFijJ-pOvejvNQYZBhow7uRz2fJ9DI-vVJXW_B-2AvT8UOMATe2DPe9ZgPngPRNKycDCsl7qztwlyt6uwXV55E8iomzwpErnHSz5xVyeTxD101vdAti3s6UvIlgnQs6uQ9fhsF3mSffjtZtdaR__sHr-L9P9wB2e2wqjjtleghbxu7B_rGldfn3a_FWuGxRF4bfg53JUCluH35NaTG7cqnwSyvmjSj7OTe14DivIJApVswR2zoBKwzXpSWXsBANHRYCaaymEfOxJm-7uBZLFA2TggjLWZnUiKS93U5LvgYHj4UUXfB4rkm24phS8wguTz5cTKZ-X-aB9IMApZ9LrJGAX16mKo8rTElrUJoyqpMyy6VWVYq1yVCiKfMETSrrqK5RK0wMmrqKHsO2XVpzAILgC02VzlCHeayokyF8lymDsa4ypbQHr4fpLn50bB7FuAqyunAv3IPDQRGK3qCbgmBWkMqY4JEHr8Zmes_8f6W0ZrlmGRmw75CBB086vRnvEtF4olRR72xDo0YBpvnebLHzr47um0n6MsK5HrxzGvP3kRens4k7efrvoi9hZ3pxflacfZx9egb3JJc3dknph7DdrtbmOWGutnrhTOs3G78taA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NIcFe-LExKAwwCCFeMiVOnDjiaeqoyoAKISbtASlKbJ-oVtypSR_G_8D_zNn5oZUJCfFSVfI5dePv4s-X83cAr7CMuMqiPFCJEUGSGhNIofMgzkuFocRQGXca-dMsnZ4mJ2fibAve9mdhWn2IIeDmPMM_r52DX2i86uTkPxEt3uIG3EzSUDpIH38ZtKOcblY0SIUTNDtZIZ_G03fdXIyuMczriZJXCaxfgSZ34Vs_9jbx5Pxw3VSH6ucfso7_-efuwZ2OmbKjFkr3YcvYXdg7srQr_3HJXjOfK-qD8Ltwe9zXiduDX1Payq58IvzSsnnNym7GjWYuysuIYrKVU4htvIFlxlWlpQVhwWr6WDCkoZqazYeKvM3iki2R1U4ShFmXk0mNSNhtz1m6a7jQMeOsDR3PFdlWLqJUP4DTybuv42nQFXkgdBCdDHKOGon25WUm8qTCjDCD3JSxTkuZcyWqDLWRyNGUeYom4zrWGpXA1KDRVbwP23ZpzSNgRF5oppREFeWJoE6G2J0UBhNVSSHUCF72s11ctFoexbAHsqrwN3wEBz0Ois6d64JIVpjxhMjRCF4MzXSf3duV0prl2tnw0K0cPBzBwxY2w6_ENJ44E9RbbgBqMHAi35stdv7di307iT5JLHcEbzxg_j7y4mQ29l8e_7vpc7j1-XhSfHw_-_AEdrirbewz0g9gu1mtzVMiXE31zDvWb6SsLCA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypertension+is+associated+with+the+reduction+in+epidermal+small+fibres+independently+of+sural+nerve+inflammation+in+type+2+diabetic+subjects&rft.jtitle=Journal+of+neurochemistry&rft.au=Wang%2C+Zhenchao&rft.au=Kushibiki%2C+Hanae&rft.au=Tarusawa%2C+Takefusa&rft.au=Osonoi%2C+Sho&rft.date=2025-02-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=169&rft.issue=2&rft.epage=n%2Fa&rft_id=info:doi/10.1111%2Fjnc.16235&rft.externalDBID=10.1111%252Fjnc.16235&rft.externalDocID=JNC16235 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |